Update on lymphatic mapping and sentinel node biopsy in the management of patients with melanocytic tumours

References

• Cochran AJ, Roberts A, Wen D-R, et al. Optimized assessment of sentinel lymph nodes for metastatic melanoma: Implications for regional surgery and overall treatment planning. Ann Surg Oncol 2004; 11(3 Suppl): 1565–615.
   Google Scholar
• Lucci A, Turner RR, Morton DL. Carbon dye as an adjunct to isosulfan blue dye for sentinel lymph node dissection. Surgery 1999; 126: 48–53.
   Google Scholar
• Haigh PI, Lucci A, Turner RR, et al. Carbon dye histologically confirms the identity of sentinel nodes in cutaneous melanoma. Cancer 2001; 92: 535–41.
   PubMed Web of Science ®Google Scholar
• Morton DL, Hoon DSB, Cochran AJ, et al. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg 2003; 238: 538–49.
   PubMed Web of Science ®Google Scholar
• Cochran AJ, Pihl E, Wen D-R, et al. Zoned immune suppression of lymph nodes draining malignant melanoma: Histologic and immuno-histologic studies. J Natl Cancer Inst 1987; 78: 399–405.
   Google Scholar
• Huang RR, Wen DR, Guo J, et al. Selective modulation of paracortical dendritic cells and T lymphocytes in breast cancer sentinel lymph nodes. Breast J 2000; 6: 225–32.
   PubMedGoogle Scholar
• Cochran AJ, Morton DL, Stern S, et al. Sentinel lymph nodes show profound downregulation of antigen-presenting cells of the para-cortex: Implications for tumor biology and treatment. Mod Pathol 2001; 14: 604–8.
   PubMed Web of Science ®Google Scholar
• Lana A-M, Wen D-R, Cochran AJ. The morphology, immunophe-notype and distribution of paracortical dendritic leukocytes in lymph nodes regional to cutaneous melanoma. Melanoma Res 2001; 11: 1–10.
   Google Scholar
• Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392–9.
   PubMed Web of Science ®Google Scholar
• Cochran AJ, Roberts AA, Saida T. The place of lymphatic mapping and sentinel node biopsy in oncology. Int J Clin Oncol 2003; 8: 139–50.
   Google Scholar
• Cochran AJ. Surgical pathology remains pivotal in the evaluation of 'sentinel' lymph nodes. Am J Surg Pathol 1999; 23: 1169–72.
   PubMed Web of Science ®Google Scholar
• Singletary SE, Byers RM, Shallenberger R, et al. Prognostic factors in patients with regional cervical nodal metastases from cutaneous malignant melanoma. Am J Surg 1986; 152: 371–5.
   PubMed Web of Science ®Google Scholar
• Starz H, Balda BR, Kramer KU, et al. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer 2001; 91: 2110–21.
   PubMed Web of Science ®Google Scholar
• Cochran AJ, Lana AMA, Wen D-R. Histomorphometry in the assessment of prognosis in Stage II melanoma. Am J Surg Pathol 1989; 13: 600–4.
   PubMed Web of Science ®Google Scholar
• Cochran AJ, Morton DL, Johnson TD, et al. Prediction of outcome and tumor-status of the non-sentinel node in melanoma patients with a positive sentinel node. Mod Pathol 2000; 13: 61 (Abstr).
   Google Scholar
• Carson KF, Wen D-R, Li P-X, et al. Nodal nevi and cutaneous melanomas. Am J Surg Pathol 1996; 20: 834–40.
   PubMed Web of Science ®Google Scholar
• Cochran AJ. The pathologist's role in sentinel lymph node evaluation. Semin Nud Med 2000; 30: 11–7.
   PubMed Web of Science ®Google Scholar
• Cochran AJ. Sentinel lymph node pathology. Progress in Pathology 2001; 5: 45–56.
   Google Scholar
• Cochran AJ, Roberts AA, Saida T. The place of lymphatic mapping and sentinel node biopsy in oncology. Int J Clin Oncol 2003; 8: 139–50.
   Google Scholar
• Wen D-R, Huang R-R, Binder S, Morton DL, Cochran AJ. Evaluation of melanoma in non-sentinel nodes: How much is enough? Mod Pathol 2004; 17 (Suppl 1): 100A.
   Google Scholar
• Cochran AJ, Wen D-R, Huang R-R, et al. Prediction of metastatic melanoma in non-sentinel nodes and clinical outcome based on the primary melanoma and the sentinel node. Mod Pathol 2004; 17: 747–55.
   Google Scholar
• Wen D-R, Huang R-R, Starz H, et al. Prognostic factors predict non-sentinel node status in melanoma patients. Mod Pathol 2003; 16: 101A.
   Google Scholar
• Kelley SW, Cockerell CJ. Sentinel lymph node biopsy as an adjunct to management of histologically difficult to diagnose melanocytic lesions: a proposal. J Am Acad Dermatol 2000; 42: 527–30.
   PubMed Web of Science ®Google Scholar
• Zuckerman R, Maier JP, Guiney WB Jr, Huntsman WT, Mooney EK. Pediatric melanoma: confirming the diagnosis with sentinel node biopsy. Ann Plast Surg 2001; 46: 394–9.
   Google Scholar
• Lohmann CM, Coit DG, Brady MS, Berwick M, Busam KJ. Sentinel lymph node biopsy in patients with diagnostically controversial spitzoid melanocytic tumors. Am J Surg Pathol 2002; 26: 47–55.
   Google Scholar
• Su LD, Fullen DR, Sondak VK, Johnson TM, Lowe L. Sentinel lymph node biopsy for patients with problematic spitzoid melanocytic lesions: a report on 18 patients. Cancer 2003; 97: 499–507.
   Google Scholar
• Cook MG, Green MA, Anderson B, et al. The development of optimal pathological assessment of sentinel lymph nodes for melanoma. J Pathol 2003; 200: 314–9.
   PubMed Web of Science ®Google Scholar
• Starz H, Haas CJ, Schulz GM, Balda BR. Tyrosinase RT-PCR as a supplement to histology for detecting melanoma and nevus cells in paraffin sections of sentinel lymph nodes. Mod Pathol 2003; 16: 920–9.
   PubMed Web of Science ®Google Scholar
• Wagner JD, Davidson D, Coleman JJ 3rd, et al. Lymph node tumor volumes in patients undergoing sentinel lymph node biopsy for cutaneous melanoma. Ann Surg Oncol 1999; 6: 398–04.
   Google Scholar
• Ranieri JM, Wagner JD, Azuaje R, et al. Prognostic importance of lymph node tumor burden in melanoma patients staged by sentinel node biopsy. Ann Surg Oncol 2002; 9: 975–81.
   PubMed Web of Science ®Google Scholar